Free Trial
CVE:HEM

Hemostemix (HEM) Stock Price, News & Analysis

Hemostemix logo
C$0.14 -0.01 (-3.57%)
As of 07/18/2025 09:30 AM Eastern

About Hemostemix Stock (CVE:HEM)

Key Stats

Today's Range
C$0.14
C$0.14
50-Day Range
C$0.08
C$0.15
52-Week Range
C$0.04
C$0.43
Volume
40,000 shs
Average Volume
390,984 shs
Market Capitalization
C$19.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemostemix and its competitors with MarketBeat's FREE daily newsletter.

HEM Stock News Headlines

Hemostemix Closing $3,000,000 Private Placement
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Hemostemix Closes $469,366 Private Placement
See More Headlines

HEM Stock Analysis - Frequently Asked Questions

Hemostemix's stock was trading at C$0.12 at the start of the year. Since then, HEM shares have increased by 12.5% and is now trading at C$0.14.

Shares of HEM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hemostemix investors own include Iplayco (IPC), Capricor Therapeutics (CAPR), Golden Share Resources (GSH), Nuvilex (PMCB), Algernon Pharmaceuticals (AGNPF), Defense Metals (DFMTF) and NIO (NIO).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:HEM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.00 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
37.07%
Return on Assets
-349.24%

Debt

Debt-to-Equity Ratio
-55.07
Current Ratio
0.04
Quick Ratio
0.48

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.01 per share
Price / Cash Flow
10.77
Book Value
C($0.10) per share
Price / Book
-1.36

Miscellaneous

Outstanding Shares
145,727,000
Free Float
N/A
Market Cap
C$19.67 million
Optionable
Not Optionable
Beta
0.20
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:HEM) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners